Patent · US Expired

Stent containing rapamycin or its analogs using a modified stent

US6808536B2 · kind B2 · utility

85Cited by

78References

6Claims

0Family size

Inventors

Carol Wright · Pittsburgh, US
Gerard Llanos · Stewartsville, US
Ronald Rakos · Neshanic Station, US
Kristen King · Hoboken, US

Key dates

Filing date	Apr 7, 2003
Grant date	Oct 26, 2004
Priority date	—
Expiry date	Apr 7, 2023

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61L2300/606
WIPO fieldMedical technology
WIPO sectorInstruments

Abstract

Delivery of rapamycin locally, particularly from an intravascular stent, directly from micropores in the stent body or mixed or bound to a polymer coating applied on stent, to inhibit neointimal tissue proliferation and thereby prevent restenosis. This invention also facilitates the performance of the stent in inhibiting restenosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.